Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
Clinical trial NCT05493683 · UNKNOWN
Trial details
- NCT number
- NCT05493683
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2025-07-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.